Kashani-Sabet M - Search Results

1

Ribozyme-mediated targeting of IkappaBgamma inhibits melanoma invasion and metastasis.

Torabian SZ, de Semir D, Nosrati M, Bagheri S, Dar AA, Fong S, Liu Y, Federman S, Simko J, Haqq C, Debs RJ, Kashani-Sabet M. Torabian SZ, et al. Am J Pathol. 2009 Mar;174(3):1009-16. doi: 10.2353/ajpath.2009.080207. Epub 2009 Jan 29. Am J Pathol. 2009. PMID: 19179607 Free PMC article.

2

Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells.

Suzuki T, Anderegg B, Ohkawa T, Irie A, Engebraaten O, Halks-Miller M, Holm PS, Curiel DT, Kashani-Sabet M, Scanlon KJ. Suzuki T, et al. Gene Ther. 2000 Feb;7(3):241-8. doi: 10.1038/sj.gt.3301065. Gene Ther. 2000. PMID: 10694801

3

Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice.

Kashani-Sabet M, Liu Y, Fong S, Desprez PY, Liu S, Tu G, Nosrati M, Handumrongkul C, Liggitt D, Thor AD, Debs RJ. Kashani-Sabet M, et al. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3878-83. doi: 10.1073/pnas.002025599. Epub 2002 Mar 12. Proc Natl Acad Sci U S A. 2002. PMID: 11891271 Free PMC article.

4

Tumor vascularity in the prognostic assessment of primary cutaneous melanoma.

Kashani-Sabet M, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR 3rd. Kashani-Sabet M, et al. J Clin Oncol. 2002 Apr 1;20(7):1826-31. doi: 10.1200/JCO.2002.07.082. J Clin Oncol. 2002. PMID: 11919240

5

Altered clinical course of malignant melanoma in HIV-positive patients.

Rodrigues LK, Klencke BJ, Vin-Christian K, Berger TG, Crawford RI, Miller JR 3rd, Ferreira CM, Nosrati M, Kashani-Sabet M. Rodrigues LK, et al. Arch Dermatol. 2002 Jun;138(6):765-70. doi: 10.1001/archderm.138.6.765. Arch Dermatol. 2002. PMID: 12056957

6

Ribozyme therapeutics.

Kashani-Sabet M. Kashani-Sabet M. J Investig Dermatol Symp Proc. 2002 Dec;7(1):76-8. doi: 10.1046/j.1523-1747.2002.19642.x. J Investig Dermatol Symp Proc. 2002. PMID: 12518796 Free article. Review.

7

Functional identification of distinct sets of antitumor activities mediated by the FKBP gene family.

Fong S, Mounkes L, Liu Y, Maibaum M, Alonzo E, Desprez PY, Thor AD, Kashani-Sabet M, Debs RJ. Fong S, et al. Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14253-8. doi: 10.1073/pnas.2332307100. Epub 2003 Nov 11. Proc Natl Acad Sci U S A. 2003. PMID: 14612567 Free PMC article.

8

NF-kappa B in the vascular progression of melanoma.

Kashani-Sabet M, Shaikh L, Miller JR 3rd, Nosrati M, Ferreira CM, Debs RJ, Sagebiel RW. Kashani-Sabet M, et al. J Clin Oncol. 2004 Feb 15;22(4):617-23. doi: 10.1200/JCO.2004.06.047. J Clin Oncol. 2004. PMID: 14966085

9

Ribozymes in the age of molecular therapeutics.

Bagheri S, Kashani-Sabet M. Bagheri S, et al. Curr Mol Med. 2004 Aug;4(5):489-506. doi: 10.2174/1566524043360410. Curr Mol Med. 2004. PMID: 15267221 Review.

10

Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.

Nosrati M, Li S, Bagheri S, Ginzinger D, Blackburn EH, Debs RJ, Kashani-Sabet M. Nosrati M, et al. Clin Cancer Res. 2004 Aug 1;10(15):4983-90. doi: 10.1158/1078-0432.CCR-04-0134. Clin Cancer Res. 2004. PMID: 15297398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters